iShares Biotechnology ETF $IBB Shares Acquired by Outlook Wealth Advisors LLC

Outlook Wealth Advisors LLC increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 311.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,898 shares of the financial services provider’s stock after purchasing an additional 9,009 shares during the quarter. Outlook Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,505,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Pension & Wealth Management Advisors Inc. acquired a new position in iShares Biotechnology ETF in the 2nd quarter valued at approximately $28,000. Trust Co. of Vermont acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at $44,000. GKV Capital Management Co. Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 1st quarter valued at $49,000. Compass Financial Management LLC purchased a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $56,000. Finally, Matrix Private Capital Group LLC purchased a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at $68,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.1%

NASDAQ IBB opened at $217.61 on Friday. iShares Biotechnology ETF has a 1-year low of $154.62 and a 1-year high of $222.29. The firm’s fifty day simple moving average is $208.43 and its 200-day simple moving average is $184.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 18th. Shareholders of record on Tuesday, September 15th were paid a $0.0112 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.0%. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date was Tuesday, September 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.